This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Mojo Organics, Inc. Appoints J.R. LeShufy To The Company's Board Of Directors

Stocks in this article: MOJO

NEW YORK, Feb. 2, 2012 /PRNewswire/ -- Mojo Organics, Inc. (OTCBB: MOJO) ("Mojo" or the "Company") today announced the appointment of J. Robert ("J.R.") LeShufy to the company's Board of Directors. LeShufy is a founding investor in Mojo and brings a diverse business background to the Company. He has been an entrepreneur in a wide range of ventures from the oil industry, construction, and dredging. He is currently a senior advisor to The Broadsmoore Group, a privately held investment advisory and merchant banking firm.

"We are pleased to welcome J.R. to Mojo's board. His significant experience in launching companies both here and abroad will be instrumental in guiding the company's growth," said Glenn Simpson, CEO of Mojo. "We look forward to J.R.'s leadership as we continue developing consumer products."

In the 1990's, LeShufy formed the second approved joint venture in the former Soviet Union in the Siberian oil fields of the Komi Region with his partner Samson Drilling of Oklahoma. He also worked with Brown and Root, a division of Halliburton, to help the company access the oil fields in Kazakhstan.

After a meeting with the Komarov Institute in St. Petersburg, the world's oldest botanical gardens started by Peter the Great, LeShufy formed a joint venture known as Panax Pharmaceuticals. During that time, he worked with the Institute of Traditional Medicine in Guang-Xi, China, to incorporate Chinese botanical products for Western medicine. Back in the U.S., he took Panax public. The company subsequently changed its name to Inkine Pharmaceutical and was sold to Salix Pharmaceutical for $200 million.

In 2004, LeShufy was a founder of Glyconix Corp., a company specializing in sugar chemistry to improve the efficacy of small molecule drugs. Prior to that, he was on the board of IMT Inc., a company whose mission was to evaluate covert Navy projects. LeShufy was granted top level security in this capacity. He volunteered and served in the U.S. Army Air Corps.  

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,814.94 -2.96 -0.02%
S&P 500 2,067.03 -2.38 -0.12%
NASDAQ 4,758.2520 +3.36 0.07%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs